475 related articles for article (PubMed ID: 33754035)
1. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria.
Liu Y; Tong Z; Shi J; Li R; Upton M; Wang Z
Theranostics; 2021; 11(10):4910-4928. PubMed ID: 33754035
[TBL] [Abstract][Full Text] [Related]
2. Combination approaches to combat multidrug-resistant bacteria.
Worthington RJ; Melander C
Trends Biotechnol; 2013 Mar; 31(3):177-84. PubMed ID: 23333434
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic Adjuvants: Rescuing Antibiotics from Resistance.
Wright GD
Trends Microbiol; 2016 Nov; 24(11):862-871. PubMed ID: 27430191
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming of antibiotics to combat antimicrobial resistance.
Dubey KK; Indu ; Sharma M
Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000168. PubMed ID: 32776618
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
[TBL] [Abstract][Full Text] [Related]
6. Drug combinations: a strategy to extend the life of antibiotics in the 21st century.
Tyers M; Wright GD
Nat Rev Microbiol; 2019 Mar; 17(3):141-155. PubMed ID: 30683887
[TBL] [Abstract][Full Text] [Related]
7. Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review.
Foletto VS; da Rosa TF; Serafin MB; Bottega A; Hörner R
Int J Antimicrob Agents; 2021 Sep; 58(3):106380. PubMed ID: 34166776
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal.
Tarín-Pelló A; Suay-García B; Pérez-Gracia MT
Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1095-1108. PubMed ID: 35576494
[TBL] [Abstract][Full Text] [Related]
9. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
Konreddy AK; Rani GU; Lee K; Choi Y
Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy: the propitious rationale for drug development.
Phougat N; Khatri S; Singh A; Dangi M; Kumar M; Dabur R; Chhillar AK
Comb Chem High Throughput Screen; 2014 Jan; 17(1):53-67. PubMed ID: 24138510
[TBL] [Abstract][Full Text] [Related]
11. Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.
Furniss RCD; Kaderabkova N; Barker D; Bernal P; Maslova E; Antwi AAA; McNeil HE; Pugh HL; Dortet L; Blair JMA; Larrouy-Maumus G; McCarthy RR; Gonzalez D; Mavridou DAI
Elife; 2022 Jan; 11():. PubMed ID: 35025730
[TBL] [Abstract][Full Text] [Related]
12. Use of adjuvants in the treatment of Acinetobacter baumannii.
Pachón-Ibáñez ME; Smani Y; Pachón J
Expert Rev Anti Infect Ther; 2016; 14(2):153-5. PubMed ID: 26620637
[TBL] [Abstract][Full Text] [Related]
13. Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review.
Annunziato G
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766441
[TBL] [Abstract][Full Text] [Related]
14. Repurposing Non-Antibiotic Drugs Auranofin and Pentamidine in Combination to Combat Multidrug-Resistant Gram-Negative Bacteria.
Yu Y; Zhao H; Lin J; Li Z; Tian G; Yang YY; Yuan P; Ding X
Int J Antimicrob Agents; 2022 May; 59(5):106582. PubMed ID: 35378227
[TBL] [Abstract][Full Text] [Related]
15. Improving therapy of severe infections through drug repurposing of synergistic combinations.
Cheng YS; Williamson PR; Zheng W
Curr Opin Pharmacol; 2019 Oct; 48():92-98. PubMed ID: 31454708
[TBL] [Abstract][Full Text] [Related]
16. Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant
Cheng YS; Sun W; Xu M; Shen M; Khraiwesh M; Sciotti RJ; Zheng W
Front Cell Infect Microbiol; 2018; 8():438. PubMed ID: 30662875
[TBL] [Abstract][Full Text] [Related]
17. Synergistic combination of carvedilol, amlodipine, amitriptyline, and antibiotics as an alternative treatment approach for the susceptible and multidrug-resistant A. baumannii infections via drug repurposing.
Ugurel E; Turgut-Balik D
Eur J Clin Microbiol Infect Dis; 2023 Sep; 42(9):1063-1072. PubMed ID: 37428238
[TBL] [Abstract][Full Text] [Related]
18. Novel antimicrobial strategies to treat multi-drug resistant Staphylococcus aureus infections.
Douglas EJA; Wulandari SW; Lovell SD; Laabei M
Microb Biotechnol; 2023 Jul; 16(7):1456-1474. PubMed ID: 37178319
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic adjuvants: multicomponent anti-infective strategies.
Kalan L; Wright GD
Expert Rev Mol Med; 2011 Feb; 13():e5. PubMed ID: 21342612
[TBL] [Abstract][Full Text] [Related]
20. Anthelmintic Drugs for Repurposing against Gram-Negative Bacilli Infections.
Canturri AM; Smani Y
Curr Med Chem; 2022; 30(1):59-71. PubMed ID: 35838224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
